secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cigna Group (CI)
CIK:        0001739940
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001140361-25-039777
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cigna Q3 revenue up 10% to $69.7B, adjusted EPS $7.83, reaffirms FY2025 guidance
--------------------------------------------------------------------------------

- Revenue $69.7B (+10% YoY); GAAP net income $1.9B ($6.98 EPS) vs $0.7B ($2.63) in Q3 2024.
- Adjusted EPS $7.83 vs $7.51 YoY; reaffirms FY2025 adjusted EPS outlook at least $29.60.
- Evernorth segment revenue +15%, adj income +1%; Cigna Healthcare rev -18% due to HCSC divestiture.
- Announced new rebate-free pharmacy benefit model to lower costs and improve transparency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739940/000114036125039777/0001140361-25-039777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739940/000114036125039777/ef20057735_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-039777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer